New Vaccine Development: Establishing Priorities: Volume I, Diseases of Importance in the United States
View larger
  • Status: Final Book
  • Downloads: 152
New Vaccine Development:
Establishing Priorities: Volume I, Diseases of Importance in the United States
(1985)
Overview

Authors

Topics

Publication Info

472 pages | 8 1/2 x 11
Contents

Table of Contents

skim chapter
Front Matter i-xiv
1. Summary 1-16
2. Priority Setting for Health Related Investments: A Review of Methods 17-27
3. Overview of the Analytic Approach 28-38
4. Comparison of Disease Burdens and Costs 39-58
5. Predictions on Vaccine Development 59-66
6. Assessing the Likely Utilization of New Vaccines 67-91
7. Calculation and Comparison of the Health Benefits and Costs Associated with Candidate Vaccines 92-120
8. Additional Issues in the Selection of Priorities for Accelerated Vaccine Development 121-126
9. Findings, Conclusions, and Recommendations 127-148
Appendix A: Some Examples of the Application of Project Selection Method 149-152
Appendix B: Pathogenic Agents for Which Accelerated Vaccine Development Does Not Appear Appropriate 153-170
Appendix C: Prospects for Immunizing Against Bordetella pertussis 171-182
Appendix D: Prospects for Immunizing Against Coccidioidomycosis 183-197
Appendix E: Prospects for Immunizing Against Cytomegalovirus 198-234
Appendix F: Prospects for Immunizing Against Hemophilus influenzae type b 235-251
Appendix G: Prospects for Immunizing Against Hepatitis A Virus 252-260
Appendix H: Prospects for Immunizing Against Hepatitis B Virus 261-279
Appendix I: Prospects for Immunizing Against Herpes Simplex Viruses 1 and 2 280-312
Appendix J: Prospects for Immunizing Against Herpesvirus varicellae 313-341
Appendix K: Prospects for Immunizing Against Influenza Viruses A and B 342-364
Appendix L: Prospects for Immunizing Against Neisseria gonorrhoeae 365-384
Appendix M: Prospects for Immunizing Against Parainfluenza Viruses 385-396
Appendix N: Prospects for Immunizing Against Respiratory Syncytial Virus 397-409
Appendix O: Prospects for Immunizing Against Rotavirus 410-423
Appendix P: Prospects for Immunizing Against Streptococcus group B 424-439
Appendix Q: Questionnaire for Assessing Morbidity-Mortality Trade-Offs 440-443
Appendix R: Technical Notes 444-444
Appendix S: Biographical Notes on Committee Members 445-449
Appendix T: Additional Sources of Advice to the Committee 450-452
Index 453-458
Related Resources
Research Tools

Suggested Citation

National Research Council. New Vaccine Development: Establishing Priorities: Volume I, Diseases of Importance in the United States. Washington, DC: The National Academies Press, 1985.

Import this citation to:

Copyright Information

The National Academies Press (NAP) has partnered with Copyright Clearance Center's Rightslink service to offer you a variety of options for reusing NAP content. Through Rightslink, you may request permission to reprint NAP content in another publication, course pack, secure website, or other media. Rightslink allows you to instantly obtain permission, pay related fees, and print a license directly from the NAP website. The complete terms and conditions of your reuse license can be found in the license agreement that will be made available to you during the online order process. To request permission through Rightslink you are required to create an account by filling out a simple online form. The following list describes license reuses offered by the National Academies Press (NAP) through Rightslink:

  • Republish text, tables, figures, or images in print
  • Post on a secure Intranet/Extranet website
  • Use in a PowerPoint Presentation
  • Distribute via CD-ROM
  • Photocopy

Click here to obtain permission for the above reuses. If you have questions or comments concerning the Rightslink service, please contact:

Rightslink Customer Care
Tel (toll free): 877/622-5543
Tel: 978/777-9929
E-mail: customercare@copyright.com
Web: http://www.rightslink.com

To request permission to distribute a PDF, please contact our Customer Service Department at 800-624-6242 for pricing.

To request permission to translate a book published by the National Academies Press or its imprint, the Joseph Henry Press, please click here to view more information.

Related Books more

More by the Board on Population Health and Public Health Practice more